P2X7 receptors induce degranulation in human mast cells

Purinergic Signalling

Volumn 12, Issue 2, 2016, Pages 235-246

  Wareham, Kathryn J ^a   Seward, Elizabeth P ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

ATP; Degranulation; Mast cells; P2X

Indexed keywords

ADENOSINE TRIPHOSPHATE; BETA N ACETYLHEXOSAMINIDASE; CALCIUM; HISTAMINE; ICOSANOID; NF449; PURINERGIC P2X RECEPTOR ANTAGONIST; PURINERGIC P2X1 RECEPTOR; PURINERGIC P2X7 RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; CYTOTOXICITY ASSAY; DEGRANULATION; HUMAN; HUMAN CELL; IMAGING; IMMUNE RESPONSE; MAST CELL; MAST CELL LEUKEMIA; SIGNAL TRANSDUCTION; CALCIUM SIGNALING; CELL CULTURE; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

CALCIUM SIGNALING; CELL DEGRANULATION; CELLS, CULTURED; HUMANS; MAST CELLS; RECEPTORS, PURINERGIC P2X7;

EID: 84959144565     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-016-9497-4     Document Type: Article

References (46)

1. Beghdadi W, MadjËne LC, Benhamou M, Charles N, Gautier G, Launay P, Blank U (2011) Mast cells as cellular sensors in inflammation and immunity. Frontiers in Immunology 2. doi:10.3389/fimmu.2011.00037
2. Gilfillan AM, Beaven MA (2011) Regulation of mast cell responses in health and disease. Crit Rev Immunol 31(6):475–529
3. Barbara G, Wang B, Stanghellini V, de Giorgio R, Cremon C, Di Nardo G, Trevisani M, Campi B, Geppetti P, Tonini M, Bunnett NW, Grundy D, Corinaldesi R (2007) Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 132(1):26–37. doi:10.1053/j.gastro.2006.11.039
4. Héron A, Dubayle D (2013) A focus on mast cells and pain. J Neuroimmunol 264 (1–2):1-7. 10.1016/j.jneuroim.2013.09.018
5. Holdsworth SR, Summers SA (2008) Role of mast cells in progressive renal diseases. J Am Soc Nephrol 19(12):2254–2261. doi:10.1681/asn.2008010015
6. Idzko M, Ferrari D, Eltzschig HK (2014) Nucleotide signalling during inflammation. Nature 509(7500):310–317. doi:10.1038/nature13085
7. Burnstock G, Boeynaems JM (2014) Purinergic signalling and immune cells. Purinergic Signal 10(4):529–564. doi:10.1007/s11302-014-9427-2
8. Sudo N, Tanaka K, Koga Y, Okumura Y, Kubo C, Nomoto K (1996) Extracellular ATP activates mast cells via a mechanism that is different from the activation induced by the cross-linking of Fc receptors. J Immunol 156(10):3970–3979
9. Bennett JP, Cockcroft S, Gomperts BD (1981) Rat mast cells permeabilized with ATP secrete histamine in response to calcium ions buffered in the micromolar range. J Physiol 317:335–345
10. Burnstock G, Kennedy C (1985) Is there a basis for distinguishing two types of P2-purinoceptor? GenPharmacol 16:433–440
11. Egan TM, Khakh BS (2004) Contribution of calcium ions to P2X channel responses. J Neurosci 24(13):3413–3420
12. Shigetomi E, Kato F (2004) Action potential-independent release of glutamate by Ca2+ entry through presynaptic P2X receptors elicits postsynaptic firing in the brainstem autonomic network. J Neurosci 24(12):3125–3135. doi:10.1523/JNEUROSCI.0090-04.2004
13. Ferrari D, Chiozzi P, Falzoni S, Dal Susino M, Melchiorri L, Baricordi OR, Di Virgilio F (1997) Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol 159(3):1451–1458
14. Mulryan K, Gitterman DP, Lewis CJ, Vial C, Leckie BJ, Cobb AL, Brown JE, Conley EC, Buell G, Pritchard CA, Evans RJ (2000) Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature 403(6765):86–89. doi:10.1038/47495
15. Dahlquist R (1974) Determination of ATP-induced 45calcium uptake in rat mast cells. Acta Pharmacol Toxicol (Copenh) 35(1):1–10
16. Saito H, Sakaguchi N, Ebisawa M, Matsumoto K, Akasawa A, Iikura Y (1991) The stimuli releasing histamine from murine bone marrow-derived mast cells. 2. Mechanisms involved in histamine release induced by extracellular ATP and its metabolites. Arerugi 40(7):680–688
17. Tatham PE, Lindau M (1990) ATP-induced pore formation in the plasma membrane of rat peritoneal mast cells. J Gen Physiol 95(3):459–476
18. Dahlquist R (1974) Relationship of uptake of sodium and 45calcium to ATP-induced histamine release from rat mast cells. Acta Pharmacol Toxicol (Copenh) 35(1):11–22
19. McCloskey MA, Fan Y, Luther S (1999) Chemotaxis of rat mast cells toward adenine nucleotides. J Immunol 163:970–977
20. Schulman ES, Glaum MC, Post T, Wang Y, Raible DG, Mohanty J, Butterfield JH, Pelleg A (1999) ATP modulates anti-IgE-induced release of histamine from human lung mast cells. Am J RespirCell Mol Biol 20(3):530–537
21. Feng C, Mery AG, Beller EM, Favot C, Boyce JA (2004) Adenine nucleotides inhibit cytokine generation by human mast cells through a Gs-Coupled receptor. J Immunol 173:7539–7547
22. Manthei DM, Jackson DJ, Evans MD, Gangnon RE, Tisler CJ, Gern JE, Lemanske RF Jr, Denlinger LC (2012) Protection from asthma in a high-risk birth cohort by attenuated P2X(7) function. J Allergy Clin Immunol 130(2):496–502. doi:10.1016/j.jaci.2012.05.040
23. Kurashima Y, Amiya T, Nochi T, Fujisawa K, Haraguchi T, Iba H, Tsutsui H, Sato S, Nakajima S, Iijima H, Kubo M, Kunisawa J, Kiyono H (2012) Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors. Nat Commun 3:1034. doi:10.1038/ncomms2023
24. Jacob F, Novo CP, Bachert C, Van Crombruggen K (2013) Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses. Purinergic Signalling 9(3):285–306. doi:10.1007/s11302-013-9357-4
25. Wareham K, Vial C, Wykes RCE, Bradding P, Seward EP (2009) Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells. Br J Pharmacol 157(7):1215–1224
26. Wykes RC, Lee M, Duffy SM, Yang W, Seward EP, Bradding P (2007) Functional transient receptor potential melastatin 7 channels are critical for human mast cell survival. J Immunol 179(6):4045–4052
27. Buell G, Michel AD, Lewis C, Collo G, Humphrey PP, Surprenant A (1996) P2X1 receptor activation in HL60 cells. Blood 87(7):2659–2664
28. Evans RJ, Lewis C, Buell G, Valera S, North RA, Surprenant A (1995) Pharmacological characterization of heterologously expressed ATP- gated cation channels (P 2x -purinoreceptors). MolPharmacol 48:178–183
29. Kirshenbaum AS, Akin C, Wu Y, Rottem M, Goff JP, Beaven MA, Rao VK, Metcalfe DD (2003) Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of Fc[var epsilon]RI or Fc[gamma]RI. Leuk Res 27:677–682
30. Surprenant A, Rassendren F, Kawashima E, North RA, Buell G (1996) The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272(5262):735–738
31. Di Virgilio F, Chiozzi P, Falzoni S, Ferrari D, Sanz JM, Venketaraman V, Baricordi OR (1998) Cytolytic P2X purinoceptors. Cell Death Differ 5(3):191–199. doi:10.1038/sj.cdd.4400341
32. Bulanova E, Bulfone-Paus S (2009) P2 receptor-mediated signaling in mast cell biology. Purinergic Signal. doi:10.1007/s11302-009-9173-z
33. Hauswirth AW, Escribano L, Prados A, Nuñez R, Mirkina I, Kneidinger M, Florian S, Sonneck K, Vales A, Schernthaner GH, Sanchez-Muñoz L, Sperr WR, Bühring HJ, Orfao A, Valent P (2008) CD203c is overexpressed on neoplastic mast cells in systemic mastocytosis and is upregulated upon IgE receptor cross-linking. Int J Immunopathol Pharmacol 21(4):797–806
34. Rolf MG, Brearley CA, Mahaut-Smith MP (2001) Platelet shape change evoked by selective activation of P2X1 purinoceptors with alpha, beta-methylene ATP. Thromb Haemost 85(2):303–308
35. Hechler B, Lenain N, Marchese P, Vial C, Heim V, Freund M, Cazenave JP, Cattaneo M, Ruggeri ZM, Evans R, Gachet C (2003) A role of the fast ATP-gated P2X1 cation channel in thrombosis of small arteries in vivo. J Exp Med 198:661–667
36. Gao ZG, Wei Q, Jayasekara MP, Jacobson KA (2013) The role of P2Y(14) and other P2Y receptors in degranulation of human LAD2 mast cells. Purinergic Signal 9(1):31–40. doi:10.1007/s11302-012-9325-4
37. Di Capite J, Parekh AB (2009) CRAC channels and Ca2+ signaling in mast cells. Immunol Rev 231(1):45–58. doi:10.1111/j.1600-065X.2009.00808.x
38. Vig M, Kinet JP (2009) Calcium signaling in immune cells. Nat Immunol 10(1):21–27. doi:10.1038/ni.f.220
39. Lundequist A, Pejler G (2011) Biological implications of preformed mast cell mediators. Cell Mol Life Sci 68(6):965–975. doi:10.1007/s00018-010-0587-0
40. Owen CE (2007) Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic. Pharmacol Ther 113(1):121–133. doi:10.1016/j.pharmthera.2006.07.003
41. Brown JM, Wilson TM, Metcalfe DD (2008) The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin Exp Allergy 38(1):4–18. doi:10.1111/j.1365-2222.2007.02886.x
42. Osipchuk Y, Cahalan M (1992) Cell-to-cell spread of calcium signals mediated by ATP receptors in mast cells. Nature 359:241–244
43. Driver AG, Kukoly CA, Ali S, Mustafa SJ (1993) Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 148(1):91–97. doi:10.1164/ajrccm/148.1.91
44. Idzko M, Hammad H, van Nimwegen M, Kool M, Willart MA, Muskens F, Hoogsteden HC, Luttmann W, Ferrari D, Di Virgilio F, Virchow JC Jr, Lambrecht BN (2007) Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 13(8):913–919. doi:10.1038/nm1617
45. Basoglu OK, Pelleg A, Essilfie-Quaye S, Brindicci C, Barnes PJ, Kharitonov SA (2005) Effects of aerosolized adenosine 5′-triphosphate vs adenosine 5′-monophosphate on dyspnea and airway caliber in healthy nonsmokers and patients with asthma. Chest 128(4):1905–1909. doi:10.1378/chest.128.4.1905
46. Cushley MJ, Tattersfield AE, Holgate ST (2004) Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. 1983. Br J Clin Pharmacol 58 (7):S751-755; discussion S756-758. doi:10.1111/j.1365-2125.2004.02285.x